Summary

Coenzyme Q10 Market Growth & Trends

The global coenzyme Q10 market is expected to reach USD 1.33 billion by 2030, according to a new report by Grand View Research, Inc. registering a 10.2% CAGR from 2023 to 2030. Increasing use in cosmetic formulations is a key driving factor for industry growth.

CoQ10 exhibits antioxidant properties and energy generation characteristics targeting skin repair. It emerged as the largest consumer accounting for over half of the total volume in 2015. Aging population and the resulting demand for anti-aging products to further drive growth.

Asia Pacific is poised to be the fastest-growing regional market on account of expanding industrial base with most of the manufacturing companies opening plants in China and growing major end-use industries such as pharmaceutical and dietary supplements. Latin America would follow Asia Pacific in terms of growth. The growth can be attributed to increasing use as a dietary supplement and ailment of diverse diseases.

Dietary supplements were the dominant application segment accounting for over 60% of the total market volume in 2015. Cosmetics is expected to witness the highest growth rate of 10.4% from 2016 to 2024, growth is driven by increasing use in skincare creams and lotions in compliance with usage regulations.

Coenzyme Q10 Market Report Highlights

• CoQ10 is responsible for transferring electrons and aerobic cellular respiration in diverse organisms. It is majorly found in organs that require high energy such as the liver, kidney, and heart.

• CoQ10 is sold only as a dietary supplement, restricting its potential applications in the medical industry.

• The dietary supplements segment held the largest revenue share of 60.9% in 2022. The segment growth is likely to be driven by advantageous product characteristics that include antioxidant and energy generation properties.

• North America dominated the market and accounted for the largest revenue share of 48.5% in 2022. Asia Pacific is expected to grow at the CAGR of 11.0% during the forecast period.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Application
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Coenzyme Q10 Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Industry opportunities & challenges
3.6. Coenzyme Q10 Market Analysis Tools
3.6.1. Industry Analysis - Porter’s
3.6.1.1. Supplier power
3.6.1.2. Buyer power
3.6.1.3. Substitution threat
3.6.1.4. Threat of new entrant
3.6.1.5. Competitive rivalry
3.6.2. PESTEL Analysis
3.6.2.1. Political landscape
3.6.2.2. Technological landscape
3.6.2.3. Economic landscape
3.6.2.4. Social landscape
3.6.2.5. Environmental landscape
3.6.2.6. Legal landscape
Chapter 4. Supplier Portfolio Analysis
4.1. List of Suppliers
4.2. Kraljic Matrix
4.3. Sourcing Best Practices
4.4. Negotiation Strategies
Chapter 5. Coenzyme Q10: Application Estimates & Trend Analysis
5.1. Coenzyme Q10 Market: Key Takeaways
5.2. Coenzyme Q10 Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Dietary Supplements
5.3.1. Dietary supplements market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
5.4. Pharmaceuticals
5.4.1. Pharmaceuticals market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
5.5. Cosmetics
5.5.1. Cosmetics market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
Chapter 6. Coenzyme Q10 Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Coenzyme Q10 Market by Region: Key Takeaway
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
6.3.4. Mexico
6.3.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
6.4. Europe
6.4.1. Germany
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
6.4.2. UK
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
6.4.5. Belgium
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
6.4.6. Netherlands
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
6.5.4. Malaysia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
6.5.5. South Korea
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
6.6. Rest of the World
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. KANEKA CORPORATION
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. MITSUBISHI GAS CHEMICAL COMPANY, INC.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Gnosis
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Hwail Pharmaceutical CO., LTD.
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. KYOWA HAKKO U.S.A., INC.
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. DSM Nutritional Products AG
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. PharmaEssentia Corporation
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. ZMC-USA LLC
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Nisshin Seifun Group Inc.
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives